Ivermectin is NOT effective for treating Babesia or Bartonella infections in humans
Ivermectin has no established role in treating human babesiosis or bartonellosis and should not be used for these infections. The FDA-approved indications for ivermectin are limited to strongyloidiasis and onchocerciasis, with no mention of Babesia or Bartonella 1.
For Babesiosis
The established treatment regimens are clearly defined by IDSA guidelines 2:
First-line therapy:
- Atovaquone 750 mg PO every 12 hours PLUS azithromycin (500-1000 mg day 1, then 250 mg daily) for 7-10 days
- This combination has superior tolerability with only 15% adverse effects versus 75% with the alternative regimen
Severe disease:
- Clindamycin 300-600 mg IV every 6 hours (or 600 mg PO every 8 hours) PLUS quinine 650 mg PO every 6-8 hours
- Consider exchange transfusion if parasitemia >10%, significant hemolysis, or organ compromise
Immunocompromised patients:
- Use higher azithromycin doses (600-1000 mg daily)
- May require prolonged or repeated courses
- Suppressive monthly therapy may be needed if cure is unachievable
Critical Caveats for Babesiosis
- Only treat patients with active parasitemia (visible on blood smear or positive PCR) AND symptoms 2
- Do not treat based on serology alone
- Asymptomatic patients should not be treated unless parasitemia persists >3 months
- Monitor parasitemia closely; clinical improvement should occur within 48 hours
For Bartonella
No evidence supports ivermectin use for Bartonella infections. The provided evidence only addresses flea control to prevent transmission 3, not treatment of established infection. Standard treatment for Bartonella henselae (cat scratch disease) involves antibiotics like azithromycin or doxycycline, not antiparasitic agents.
Why Ivermectin Doesn't Work
While experimental research shows ivermectin has in vitro activity against Babesia species 4, the concentrations required (IC50 of 30-98 μM) approach toxic levels in mammalian cells (EC50 of 139-288 μM). The therapeutic index is too narrow for safe human use. Additionally, veterinary studies demonstrate that ivermectin fails to prevent Babesia transmission in cattle 5, further undermining its clinical utility.
The bottom line: Use the guideline-recommended combinations of atovaquone-azithromycin or clindamycin-quinine for babesiosis. Ivermectin has no role in treating either Babesia or Bartonella infections in humans.